These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 20006858

  • 21. Comparison of seven screening methods in the diagnosis of bladder cancer.
    Sun Y, He DL, Ma Q, Wan XY, Zhu GD, Li L, Luo Y, He H, Yang L.
    Chin Med J (Engl); 2006 Nov 05; 119(21):1763-71. PubMed ID: 17097029
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F, Müller M, Schostak M, Soong R, Tabiti K, Miller K.
    Urology; 2004 Jul 05; 64(1):157-61. PubMed ID: 15245962
    [Abstract] [Full Text] [Related]

  • 24. Contribution of the prostate limits the usefulness of survivin for the detection of bladder cancer.
    Davies B, Chen J, Modugno F, Weissfeld J, Landsittel D, Dhir R, Nelson J, Getzenberg RH.
    J Urol; 2005 Nov 05; 174(5):1767-70. PubMed ID: 16217280
    [Abstract] [Full Text] [Related]

  • 25. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z, Tiwari RP, Mulherkar R, Sah NK, Prasad GB, Shrivastava BR, Bisen PS.
    Head Neck; 2009 Aug 05; 31(8):1039-48. PubMed ID: 19340865
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
    Hautmann S, Toma M, Lorenzo Gomez MF, Friedrich MG, Jaekel T, Michl U, Schroeder GL, Huland H, Juenemann KP, Lokeshwar VB.
    Eur Urol; 2004 Oct 05; 46(4):466-71. PubMed ID: 15363562
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
    Weikert S, Christoph F, Schrader M, Krause H, Miller K, Müller M.
    Int J Cancer; 2005 Aug 10; 116(1):100-4. PubMed ID: 15761870
    [Abstract] [Full Text] [Related]

  • 30. Preliminary study of diagnostic utility of molecular beacons in bladder cancer.
    Zhao J, Wang ZQ, Wang XY, Yang XJ, He D.
    Urology; 2010 Aug 10; 76(2):512.e8-13. PubMed ID: 20579701
    [Abstract] [Full Text] [Related]

  • 31. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
    Shen C, Hu L, Xia L, Li Y.
    Jpn J Clin Oncol; 2008 Nov 10; 38(11):770-6. PubMed ID: 18845519
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparison of screening methods in the detection of bladder cancer.
    Ramakumar S, Bhuiyan J, Besse JA, Roberts SG, Wollan PC, Blute ML, O'Kane DJ.
    J Urol; 1999 Feb 10; 161(2):388-94. PubMed ID: 9915409
    [Abstract] [Full Text] [Related]

  • 34. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma.
    Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW, Li MQ, Chen YC, Qian XP, Lu TJ, Yu LZ, Zhang Y, Xin DQ, Na YQ, Chen WF.
    Clin Cancer Res; 2006 Aug 15; 12(16):4851-8. PubMed ID: 16914571
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Immunostaining of cytokeratin 20 in cells from voided urine for detection of bladder cancer.
    Golijanin D, Shapiro A, Pode D.
    J Urol; 2000 Dec 15; 164(6):1922-5. PubMed ID: 11061882
    [Abstract] [Full Text] [Related]

  • 38. Increased survivin mRNA in malignant pleural effusion is significantly correlated with survival.
    Lan CC, Wu YK, Lee CH, Huang YC, Huang CY, Tsai YH, Huang SF, Tsao TC.
    Jpn J Clin Oncol; 2010 Mar 15; 40(3):234-40. PubMed ID: 19933689
    [Abstract] [Full Text] [Related]

  • 39. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.
    Ito H, Kyo S, Kanaya T, Takakura M, Koshida K, Namiki M, Inoue M.
    Clin Cancer Res; 1998 Nov 15; 4(11):2807-10. PubMed ID: 9829746
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.